Skip to main content

Performance bias

Performance bias is a systematic difference in care, attention, or behavior between study groups caused by knowing who got which treatment. In Intro to Epidemiology, it is a major threat to the validity of randomized controlled trials.

Last updated July 2026

What is performance bias?

Performance bias is the extra change in treatment, attention, or behavior that happens during a study because people know which group a participant is in. In Intro to Epidemiology, you see it most often in randomized controlled trials when providers, participants, or both are not blinded.

The big idea is simple: if someone thinks one treatment is better, they may act differently around that group. A clinician may spend more time with the new drug group, encourage them more, or watch them more closely. Participants may also change how they report symptoms or follow instructions if they know they got the active treatment or the control.

That matters because the groups are supposed to differ only by the intervention being tested. Randomization helps make the groups comparable at the start, but randomization alone does not stop biased behavior during the study. If one group gets more attention, better follow-up, or stronger encouragement, the outcome may reflect those extra influences instead of the treatment itself.

A classic way to reduce performance bias is blinding. If participants do not know what they received, they are less likely to change expectations or behavior. If care providers and outcome assessors are also blinded, the study is less likely to drift into unequal treatment that can blur the results.

You can think of performance bias as a hidden change in the study environment. The intervention is supposed to be the only real difference, but expectations can leak into the process through tone of voice, extra visits, different advice, or uneven support. That is why epidemiologists pay close attention to whether a trial was blinded and whether the groups were treated the same way after randomization.

Why performance bias matters in Intro to Epidemiology

Performance bias is one of the main reasons randomized controlled trials can still produce misleading results even when random assignment is done correctly. In Intro to Epidemiology, that makes it a direct threat to internal validity, because the study may no longer be showing the effect of the treatment alone.

This term also helps you read trials more carefully. If a paper says participants knew which treatment they got, or if providers gave one group extra follow-up, you should immediately ask whether the outcome could be partly driven by unequal care rather than the intervention itself. That changes how confidently you trust the findings.

It also connects to common trial design choices. When a study uses blinding well, or when it explains how the control group was handled, you can judge whether performance bias was likely low or high. That is a practical skill in epidemiology, since trial quality often matters as much as the result.

The concept shows up in real public health evidence too. A weight-loss intervention, a medication trial, or a counseling program can all be affected if one group gets more encouragement, more check-ins, or more enthusiasm from staff. Performance bias helps you spot those hidden differences before you accept the conclusion at face value.

Keep studying Intro to Epidemiology Unit 7

How performance bias connects across the course

Randomization

Randomization makes groups comparable at the start by assigning participants by chance, but it does not control what happens after assignment. Performance bias can still creep in if caregivers or participants change their behavior once they know the group labels. That is why randomization and equal treatment during the trial go together.

Blinding

Blinding is the main defense against performance bias because it keeps people from changing care or behavior based on expectations. When participants, providers, or both do not know group assignment, there is less chance that one group gets extra attention or different advice. In trial critiques, blinding is one of the first things to check.

Outcome measures

Performance bias can distort outcome measures if the way people act during the study changes the results you record. For example, extra follow-up can make symptoms seem better tracked in one group, or encouragement can affect self-reported outcomes. The outcome may still be measured correctly, but the process leading to it was uneven.

intention-to-treat analysis

Intention-to-treat analysis keeps participants in the groups they were originally assigned to, even if they do not follow the treatment exactly. That does not remove performance bias, but it helps preserve the fairness of the comparison. It works best when paired with good blinding and consistent study procedures.

Is performance bias on the Intro to Epidemiology exam?

A quiz question or trial critique will usually ask you to spot whether unequal care could have affected the result. If the stem says doctors knew who got the new treatment and gave that group more follow-up, you would identify performance bias and explain how it could inflate the treatment effect. If a study is described as double-blind, you would connect that design choice to lower risk of performance bias.

You may also need to compare two studies and decide which one is more trustworthy. The better answer is usually the one where both groups were treated the same way after randomization, with blinding used when possible. On short-answer or discussion prompts, name the specific behavior that could have differed, like extra encouragement, closer monitoring, or unequal contact time, and then explain why that weakens the trial’s conclusions.

Performance bias vs selection bias

Selection bias happens when the people who enter the study or are assigned to groups are not comparable from the start. Performance bias happens after assignment, when unequal care or behavior changes the experience of one group. A good shortcut is that selection bias affects who gets in, while performance bias affects what happens during the trial.

Key things to remember about performance bias

  • Performance bias is systematic difference in care, attention, or behavior between study groups after assignment.

  • It usually happens when participants or providers know which treatment group someone is in.

  • Randomization helps make groups similar at the start, but it does not stop unequal treatment during the study.

  • Blinding is the main way to reduce performance bias in randomized controlled trials.

  • When you see different follow-up, encouragement, or monitoring across groups, performance bias may be affecting the results.

Frequently asked questions about performance bias

What is performance bias in Intro to Epidemiology?

Performance bias is when knowledge of group assignment changes the care, attention, or behavior given to study participants. In epidemiology, it is a problem because it can make treatment groups look different for reasons other than the intervention itself. That weakens the validity of a randomized controlled trial.

How is performance bias different from selection bias?

Selection bias affects who ends up in the groups or study, so the groups are already different before the intervention begins. Performance bias happens after assignment, when providers or participants act differently because they know the group labels. If you remember the timing, the two are much easier to separate.

What is an example of performance bias in a clinical trial?

If a clinic staff member knows one group is getting the new drug, they might give that group more encouragement, more check-ins, or faster responses to complaints. Those extra actions can change outcomes even if the drug itself is not better. The result is a trial that mixes treatment effects with care differences.

How do researchers reduce performance bias?

The main fix is blinding, especially double-blinding when both participants and providers do not know the assignment. Researchers also try to keep follow-up, instructions, and support as similar as possible across groups. That way, the intervention stays the main difference between the groups.